This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday – Cytokinetics (NASDAQ:CYTK), Absci (NASDAQ:ABSI)

Jan 22, 2025
this-cytokinetics-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-wednesday-–-cytokinetics-(nasdaq:cytk),-absci-(nasdaq:absi)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Canaccord Genuity analyst Caitlin Burrows initiated coverage on Orthofix Medical Inc. OFIX with a Buy rating and announced a price target of $24. Orthofix Medical shares closed at $18.36 on Tuesday. See how other analysts view this stock.
  • JP Morgan analyst James Kirby initiated coverage on Sun Country Airlines Holdings, Inc. SNCY with an Overweight rating and announced a price target of $23. Sun Country Airlines shares closed at $16.63 on Tuesday. See how other analysts view this stock.
  • Goldman Sachs analyst Lizzie Dove initiated coverage on Viking Holdings Ltd VIK with a Neutral rating and announced a price target of $49. Viking Holdings shares closed at $48.49 on Tuesday. See how other analysts view this stock.
  • Stifel analyst James Condulis initiated coverage on Cytokinetics, Incorporated CYTK with a Buy rating and announced a price target of $80. Cytokinetics shares closed at $45.82 on Tuesday. See how other analysts view this stock.
  • Needham analyst Gil Blum initiated coverage on Absci Corporation ABSI with a Buy rating and announced a price target of $9. Absci shares closed at $3.22 on Tuesday. See how other analysts view this stock.

Considering buying CYTK stock? Here’s what analysts think:

Read This Next:

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Leave a comment